Man Boobs and Love Handles: Causes and Treatments

Man boobs and love handles are two of the most common body composition concerns among men in the UK, and they frequently occur together. Whether driven by excess body fat, hormonal shifts, medication side effects, or a combination of all three, understanding what is actually causing these changes is the first step towards addressing them effectively. This article explains the medical reasons behind chest and waist fat in men, how UK doctors assess and diagnose these conditions, which treatments and lifestyle changes have the strongest evidence, and when it is important to see a GP.

What causes man boobs and love handles in men?

Man boobs result from excess glandular or fatty tissue on the chest, while love handles are subcutaneous fat around the flanks; both are driven by excess caloric intake, sedentary behaviour, age-related testosterone decline, certain medications, and underlying health conditions.

Man boobs and love handles in men are caused by a combination of excess adipose (fat) tissue, hormonal imbalances, and in some cases structural changes to glandular breast tissue. The two conditions are distinct in origin, though they frequently occur together and share several underlying drivers.

Man boobs, medically referred to as gynaecomastia or pseudogynaecomastia, involve either an increase in glandular breast tissue (true gynaecomastia) or a localised accumulation of fat over the chest (pseudogynaecomastia). True gynaecomastia results from an imbalance between oestrogen and testosterone, causing glandular tissue to proliferate.^[1][2] Pseudogynaecomastia, by contrast, is purely fatty tissue and has no glandular component.

Love handles refer to the deposits of subcutaneous fat that accumulate around the flanks and lower waist. This pattern of fat storage is strongly influenced by genetics, age-related hormonal shifts, and overall energy balance. Visceral fat, which sits deeper around the abdominal organs, often accompanies love handles and carries greater metabolic risk than subcutaneous fat alone. NHS guidance notes that a waist circumference of 94 cm or above in men is associated with increased cardiometabolic risk, rising further at 102 cm or above.^[5][6]

Common contributing causes across both conditions include:

• Excess caloric intake relative to energy expenditure

• Sedentary behaviour, which reduces muscle mass and increases fat storage

• Age-related decline in testosterone, which shifts the oestrogen-to-testosterone ratio

• Certain medications, including anabolic steroids, spironolactone, anti-androgens such as finasteride, some antipsychotics such as risperidone, and cimetidine. Proton pump inhibitors have been reported in association with gynaecomastia but the evidence is less robust than for the medicines listed above

• Heavy alcohol intake, which can impair testicular function and alter sex hormone balance

• Underlying health conditions such as hypogonadism, liver disease, or thyroid dysfunction

Understanding the specific cause is important because it determines the most appropriate management approach, and some causes are fully reversible once identified.

Is it hormones, lifestyle, or both driving these changes?

In most men, both hormonal and lifestyle factors contribute: declining testosterone and rising oestrogen from adipose aromatase activity interact with poor diet, low activity, and high alcohol intake to promote fat accumulation and glandular breast tissue growth.

In most men, man boobs and love handles are driven by a combination of hormonal and lifestyle factors rather than either alone. Separating the two is clinically useful, but in practice they interact closely and reinforce one another.

Hormonal factors play a particularly prominent role in gynaecomastia. Testosterone levels in men decline gradually from around the age of 30 onwards, while oestrogen levels can remain relatively stable or even rise, particularly in men carrying excess body fat.^[8][9] Adipose tissue contains the enzyme aromatase, which converts androgens into oestrogens. This means that as body fat increases, oestrogen production can rise, which may further stimulate glandular breast tissue. Conditions such as hypogonadism, hyperthyroidism, and hyperprolactinaemia can all disrupt this balance independently of lifestyle.

Lifestyle factors are the dominant driver of love handles and pseudogynaecomastia. A sustained caloric surplus, low physical activity, poor sleep quality, and high alcohol intake all promote fat accumulation, particularly around the abdomen and flanks. Chronic stress raises cortisol levels, which encourages central fat deposition and can suppress testosterone production, creating a hormonal environment that favours fat storage.^[26][27]

The relationship is bidirectional: excess body fat worsens hormonal imbalance, and hormonal imbalance makes fat loss harder. For example, low testosterone reduces muscle mass and metabolic rate, making weight management more difficult. This cycle can be difficult to break without addressing both components simultaneously.

In younger men and adolescents, transient gynaecomastia during puberty is common and usually resolves without intervention, typically within 6 to 24 months.^[1][3] In older men, persistent or progressive breast tissue enlargement warrants clinical assessment to exclude an underlying medical cause before attributing it to lifestyle alone.

How do doctors in the UK assess and diagnose these conditions?

UK doctors use clinical history, physical examination, and blood tests including testosterone, LH, FSH, oestradiol, prolactin, and thyroid function to distinguish true gynaecomastia from pseudogynaecomastia and exclude serious causes such as breast malignancy.

UK doctors assess man boobs and love handles through a structured clinical history, physical examination, and targeted investigations, following guidance broadly aligned with NICE and NHS clinical pathways. The assessment aims to distinguish between true gynaecomastia, pseudogynaecomastia, and rarer causes such as breast malignancy, which, while uncommon in men, must be excluded.

Clinical history will typically cover:

• Duration and rate of change of symptoms

• Medication history, including recreational drugs and supplements

• Alcohol intake and dietary habits

• Symptoms of underlying conditions (fatigue, reduced libido, changes in body hair)

• Family history of hormonal or metabolic conditions

Physical examination focuses on palpating the breast tissue to distinguish firm, rubbery glandular tissue (suggesting true gynaecomastia) from soft, diffuse fatty tissue (suggesting pseudogynaecomastia). The testes are also examined, as testicular atrophy or masses can indicate hypogonadism or a hormone-secreting tumour. Waist circumference and body mass index (BMI) are recorded to quantify central adiposity.

Blood tests commonly requested include:

• Testosterone (total and free or calculated free testosterone using sex hormone-binding globulin, SHBG); samples are ideally taken in the morning, between approximately 9 am and 11 am, and a low result is usually confirmed on a second occasion^[8]

• Luteinising hormone (LH) and follicle-stimulating hormone (FSH)

• Oestradiol

• Prolactin

• Thyroid function tests

• Liver function tests

• Fasting glucose and lipid profile

• Human chorionic gonadotrophin (hCG) and alpha-fetoprotein (AFP) where a testicular or germ cell tumour is suspected

• Renal function where systemic disease is clinically indicated

If a discrete breast lump is found, or if the presentation is asymmetrical or rapidly progressive, NICE NG12 (Suspected cancer: recognition and referral) sets out criteria for an urgent suspected cancer referral (two-week wait). For men, NICE NG12 recommends considering an urgent referral for men aged 50 or over with a unilateral, firm subareolar mass with or without nipple changes. Testicular ultrasound may also be requested if a testicular abnormality is suspected. Online weight-management consultations, such as those offered by Bolt Pharmacy, a GPhC-registered UK online pharmacy, can provide an initial clinical review and signpost men to appropriate NHS or specialist services where needed.

What treatments and lifestyle changes actually work?

Lifestyle changes including a caloric deficit, resistance training, aerobic exercise, and alcohol reduction form the cornerstone of treatment; medical options include correcting underlying hormonal conditions, reviewing causative medications, and GLP-1 receptor agonists for eligible men with obesity.

Effective treatment of man boobs and love handles depends on the underlying cause, and a combination of lifestyle modification, medical management, and in some cases surgical intervention is used in UK clinical practice.

Lifestyle changes form the cornerstone of management for both conditions and have the strongest evidence base:

• Caloric deficit through diet: reducing ultra-processed foods, refined carbohydrates, and alcohol supports fat loss across the body, including the flanks and chest

• Resistance training: building muscle mass raises basal metabolic rate and improves body composition, which can support a more favourable hormonal environment over time

• Aerobic exercise: regular moderate-intensity activity (at least 150 minutes per week, in line with UK Chief Medical Officers' physical activity guidelines) reduces visceral and subcutaneous fat

• Alcohol reduction: lowering intake supports testicular function and overall sex hormone balance

• Sleep optimisation: poor sleep suppresses testosterone and raises cortisol, both of which promote fat storage^[26][27]

Medical treatments are considered when an underlying hormonal cause is identified or when lifestyle changes alone are insufficient:

• Treating the underlying condition: correcting hypothyroidism, hyperthyroidism, hypogonadism, or hyperprolactinaemia can resolve gynaecomastia without further intervention

• Medication review: stopping or switching a causative drug (under medical supervision) may lead to regression of glandular tissue, particularly if caught early

• Selective oestrogen receptor modulators (SERMs) such as tamoxifen are sometimes used off-label for gynaecomastia in specialist settings, though they are not NICE-recommended as a routine treatment. They are generally considered most effective when used within approximately 12 months of onset, while glandular tissue is still in an active phase

• GLP-1 receptor agonists such as semaglutide (Wegovy, available in doses up to 2.4 mg weekly by injection, with an oral tablet formulation at doses up to 7.2 mg weekly) or tirzepatide (Mounjaro), which is MHRA-authorised for both type 2 diabetes and chronic weight management, may be considered for eligible men with obesity-related fat accumulation, following a clinical assessment and subject to NHS or ICB commissioning criteria.^[19][20] Mounjaro is one option a prescriber may consider after an online consultation with Bolt Pharmacy, and is only prescribed where clinically appropriate

Surgical options including liposuction or mastectomy are available privately and, in some cases, through NHS referral for significant gynaecomastia causing psychological distress, though access varies by Integrated Care Board (ICB).

When should you see a GP about chest or waist fat?

See a GP promptly if you notice a firm or rapidly enlarging breast lump, nipple discharge or bleeding, asymmetrical breast enlargement, testicular changes, or symptoms of a hormonal disorder; men aged 50 or over with a unilateral firm subareolar mass may need an urgent two-week-wait referral.

Most men with man boobs and love handles do not need urgent medical attention, but certain features warrant prompt assessment by a GP to exclude serious underlying causes. Knowing when to seek help ensures that treatable conditions are not missed.

See your GP if you notice any of the following:

• A firm, tender, or rapidly enlarging lump beneath one or both nipples

• Asymmetrical breast enlargement, particularly if one side is significantly larger

• Nipple discharge, nipple inversion, or nipple bleeding of any kind

• Skin changes over the chest, such as dimpling, redness, or ulceration

• Swelling of the lymph nodes in the armpit (axillary lymphadenopathy)

• Testicular pain, swelling, or a new lump

• Symptoms suggesting a hormonal disorder: significant fatigue, reduced libido, erectile dysfunction, loss of body hair, or mood changes

• Rapid, unexplained weight gain around the abdomen without a clear dietary cause

• Breast changes that have developed alongside a new medication

For men aged 50 or over with a unilateral, firm subareolar mass with or without nipple changes, your GP may arrange an urgent suspected cancer (two-week wait) referral in line with NICE NG12 guidance.

For men with pre-existing diabetic eye disease, it is worth noting that rapid improvements in blood glucose control, which can occur with weight-loss treatments, may transiently worsen pre-existing or pre-proliferative diabetic retinopathy. Men with known diabetic retinopathy should inform their eye clinic or diabetes team before starting any intensive treatment programme.

If you are concerned but your symptoms are not urgent, contact your GP practice in the first instance. NHS 111 (by phone or at 111.nhs.uk) can provide advice if you are unsure whether your symptoms need same-day assessment. A&E attendance is appropriate only if you develop symptoms suggesting a serious acute illness, such as signs of a testicular torsion or a rapidly evolving systemic condition.

Suspected side effects from any medication, including those used for weight management, can be reported to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk. Early reporting helps the MHRA monitor the safety of medicines used across the UK population.

Scientific References

1. Gynaecomastia.
2. Gynecomastia: physiopathology, evaluation and treatment.
3. Gynecomastia in adolescent males: current understanding of its etiology, pathophysiology, diagnosis, and treatment.
4. Gynecomastia in Infants, Children, and Adolescents.
5. Adults with a large waist are 5 times more likely to get type 2 diabetes.
6. Calculate your waist to height ratio.
7. Keep the size of your waist to less than half of your height – NICE recommends.
8. The 'male menopause'.
9. Age-Related Testosterone Decline and Metabolic Determinants in 27,687 Korean Men Aged ≥40 Years: A Nationwide Population-Based Study.
10. Metabolic impact of endogenously produced estrogens by adipose tissue in females and males across the lifespan.
11. Altered Expression of Aromatase and Estrogen Receptors in Adipose Tissue From Men With Obesity or Type 2 Diabetes.
12. The Effect of Aromatase on the Reproductive Function of Obese Males.
13. Physical activity guidelines: UK Chief Medical Officers' report.
14. Physical activity guidelines for adults aged 19 to 64.
15. Tamoxifen for the management of breast events induced by non-steroidal antiandrogens in patients with prostate cancer: a systematic review.
16. Treatment strategies to prevent and reduce gynecomastia and/or breast pain caused by antiandrogen therapy for prostate cancer.
17. Medicines regulator approves up to 7.2 mg dose of semaglutide (Wegovy) for patients with obesity.
18. Wegovy | European Medicines Agency (EMA).
19. MHRA authorises diabetes drug Mounjaro (tirzepatide) for weight management and weight loss.
20. Tirzepatide | Drugs | BNF – NICE.
21. Tirzepatide.
22. Early Worsening of Diabetic Retinopathy in the Diabetes Control and Complications Trial.
23. Adverse Events Associated with Incretin-Based Therapies: A Narrative Review on Mechanisms, Clinical Management, and Risk Mitigation.
24. Beyond Glycemic Control: Ocular Effects of Glucagon-like Peptide-1 Receptor Agonists.
25. Glucagon-like Peptide-1 Receptor Agonists and Ocular Disease: Mechanisms, Evidence and Therapeutic Perspectives.
26. Clamping Cortisol and Testosterone Mitigates the Development of Insulin Resistance during Sleep Restriction in Men.
27. Age and time-of-day differences in the hypothalamo-pituitary-testicular, and adrenal, response to total overnight sleep deprivation.

Frequently Asked Questions